Bullish
How Cabaletta Bio (CABA) Is Turning Rese-cel Enrollment and New Financing Into a Clearer Autoimmune Cell Therapy Setup
Cabaletta Bio (NASDAQ:CABA) is making progress with its experimental cell therapy, rese-cel, for autoimmune diseases. The company expects to file for ...